KIF18A-mediated HCC promotion might be correlated with several abnormally activated signaling pathways, including the Akt/MMP7/9 axis to stimulate tumor invasion and migration, and the CyclinB1-related axis to promote proliferation [95]. Here, KIF18A is linked to hepatocellular carcinoma.